THE IMPACT OF PURINE DERIVATIVES THERAPY FOR PATIENTS WITH MEDICATION-RELATED OSTEONECROSIS OF THE JAW: PRELIMINARY RESULTS FROM A PILOT STUDY

• Autori principali: Nader Farajollah (Autore), Octavian Marius Dincă (Autore), George Cristian Vlădan (Autore), Tiberiu Niță (Autore), Lavinia Cristina Pădurariu (Autore), Alexandru Bucur (Autore)
• Natura: Libro
• Pubblicazione: Romanian Society of Oral Rehabilitation, 2024-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive drugs - Bisphosphonates (BPs) and RANKL inhibitor (denosumab) - prescribed for treatment of bone malignancies and severe osteoporosis. Non-surgical treatment may be a valid option for MRONJ in patients inel...